REACH Interview Series: Dan Schawbel

The Reach Interview Series is an informal dialogue between me and respected thought leaders around the theme of my new book,  Reach: A New Strategy to Help You Step Outside Your Comfort Zone, Rise to the Challenge and Build Confidence.

Today Dan Schawbel is a New York Times bestselling author, serial entrepreneur, Fortune 500 consultant, Millennial TV personality, global keynote speaker, career and workplace expert and startup advisor.  But it wasn’t always that way. Learn how Dan started as a timid college sophomore fearful of speaking in public to someone who easily and effortlessly speaks to Fortune 500 CEO’s and billionaires.  And best of all – learn how Dan’s tricks of the trade are things any of us can put into action immediately.


AVAILABLE NOW

Reach A New Strategy to Help You Step Outside Your Comfort Zone 

Prescriptive and based not only on my groundbreaking research but on my own quest to get out of my comfort zone, Reach will help you take the thing you are most afraid of doing and make it a proud part of your personal repertoire.

Learn More

Related Posts

A Ray of Hope

A Ray of Hope

Donald Trump is the President of the United States.  And it’s sent shockwaves through tens of millions of Americans, who never thought they’d hear those words. 

Read More

3 Most Common Ways American Entrepreneurs Are Culturally Blind

3 Most Common Ways American Entrepreneurs Are Culturally Blind

There is a significant problem in corporate America today with foreign workers and it’s not the problem Donald Trump is obsessed with (that there are too many foreign workers).

Read More

Is There a Global Business Code?

Is There a Global Business Code?

We all know the famous expression “When in Rome, act like the Romans.”

Read More

In a New Culture Wait to Cut to the Chase

In a New Culture Wait to Cut to the Chase

Xavier Frei wanted to get down to business. A Zurich-born manager with 10 years’ experience working in Germany and Switzerland, Xavier had just landed a few days ago in Monterrey, Mexico, at a small pharmaceutical company that was recently purchased by Xavier’s company, a major European pharmaceutical firm.

Read More